

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 5.97884877 |
| 2 | DNA deamination (GO:0045006) | 5.67034528 |
| 3 | viral transcription (GO:0019083) | 5.11583292 |
| 4 | ribosomal small subunit biogenesis (GO:0042274) | 4.94914839 |
| 5 | translational termination (GO:0006415) | 4.87288951 |
| 6 | GDP-mannose metabolic process (GO:0019673) | 4.84590853 |
| 7 | left/right pattern formation (GO:0060972) | 4.61811820 |
| 8 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.60367067 |
| 9 | mannose metabolic process (GO:0006013) | 4.58944544 |
| 10 | cotranslational protein targeting to membrane (GO:0006613) | 4.55730293 |
| 11 | protein targeting to ER (GO:0045047) | 4.49310672 |
| 12 | maturation of SSU-rRNA (GO:0030490) | 4.33495219 |
| 13 | protein localization to endoplasmic reticulum (GO:0070972) | 4.31153198 |
| 14 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.25321710 |
| 15 | translational elongation (GO:0006414) | 4.21920523 |
| 16 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.14171083 |
| 17 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.08904698 |
| 18 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.77641154 |
| 19 | protein insertion into membrane (GO:0051205) | 3.76104328 |
| 20 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.74699202 |
| 21 | protein carboxylation (GO:0018214) | 3.74699202 |
| 22 | viral life cycle (GO:0019058) | 3.68062487 |
| 23 | receptor recycling (GO:0001881) | 3.66406158 |
| 24 | UTP biosynthetic process (GO:0006228) | 3.66011991 |
| 25 | cellular protein complex disassembly (GO:0043624) | 3.65248090 |
| 26 | GTP biosynthetic process (GO:0006183) | 3.61151163 |
| 27 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.60877293 |
| 28 | UV protection (GO:0009650) | 3.60669892 |
| 29 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.59567499 |
| 30 | L-phenylalanine metabolic process (GO:0006558) | 3.55589226 |
| 31 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.55589226 |
| 32 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.55084205 |
| 33 | NADH dehydrogenase complex assembly (GO:0010257) | 3.54844723 |
| 34 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.54844723 |
| 35 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.54844723 |
| 36 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.52824844 |
| 37 | L-phenylalanine catabolic process (GO:0006559) | 3.52824844 |
| 38 | regulation of early endosome to late endosome transport (GO:2000641) | 3.52375730 |
| 39 | L-serine metabolic process (GO:0006563) | 3.49962057 |
| 40 | serine family amino acid biosynthetic process (GO:0009070) | 3.46852546 |
| 41 | proteasome assembly (GO:0043248) | 3.46330427 |
| 42 | cellular response to virus (GO:0098586) | 3.45937068 |
| 43 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.45230863 |
| 44 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.45230863 |
| 45 | translational initiation (GO:0006413) | 3.42938389 |
| 46 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.41900201 |
| 47 | protein maturation by protein folding (GO:0022417) | 3.39608916 |
| 48 | DNA strand elongation (GO:0022616) | 3.34181810 |
| 49 | UTP metabolic process (GO:0046051) | 3.31778876 |
| 50 | glyoxylate metabolic process (GO:0046487) | 3.30443664 |
| 51 | protein retention in ER lumen (GO:0006621) | 3.28985941 |
| 52 | blood coagulation, intrinsic pathway (GO:0007597) | 3.28243998 |
| 53 | metallo-sulfur cluster assembly (GO:0031163) | 3.27895368 |
| 54 | iron-sulfur cluster assembly (GO:0016226) | 3.27895368 |
| 55 | aromatic amino acid family catabolic process (GO:0009074) | 3.24570381 |
| 56 | translation (GO:0006412) | 3.19772491 |
| 57 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.18775836 |
| 58 | glycine metabolic process (GO:0006544) | 3.17133054 |
| 59 | respiratory chain complex IV assembly (GO:0008535) | 3.12265909 |
| 60 | protein complex disassembly (GO:0043241) | 3.12194985 |
| 61 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.11214139 |
| 62 | protein complex biogenesis (GO:0070271) | 3.10086898 |
| 63 | body morphogenesis (GO:0010171) | 3.09759687 |
| 64 | pseudouridine synthesis (GO:0001522) | 3.08769130 |
| 65 | ribosomal large subunit biogenesis (GO:0042273) | 3.07062420 |
| 66 | protein localization to endosome (GO:0036010) | 3.06687636 |
| 67 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.05139427 |
| 68 | disruption of cells of other organism (GO:0044364) | 3.04514350 |
| 69 | killing of cells of other organism (GO:0031640) | 3.04514350 |
| 70 | modulation by symbiont of host cellular process (GO:0044068) | 3.02951883 |
| 71 | telomere maintenance via recombination (GO:0000722) | 3.02107663 |
| 72 | indole-containing compound catabolic process (GO:0042436) | 2.95659760 |
| 73 | indolalkylamine catabolic process (GO:0046218) | 2.95659760 |
| 74 | tryptophan catabolic process (GO:0006569) | 2.95659760 |
| 75 | macromolecular complex disassembly (GO:0032984) | 2.95621202 |
| 76 | proline biosynthetic process (GO:0006561) | 2.95554831 |
| 77 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.93476010 |
| 78 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.93476010 |
| 79 | modulation by symbiont of host immune response (GO:0052553) | 2.93476010 |
| 80 | positive regulation by symbiont of host defense response (GO:0052509) | 2.93476010 |
| 81 | modulation by symbiont of host defense response (GO:0052031) | 2.93476010 |
| 82 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.93476010 |
| 83 | urea cycle (GO:0000050) | 2.93127252 |
| 84 | heme biosynthetic process (GO:0006783) | 2.92748696 |
| 85 | modulation by virus of host process (GO:0019054) | 2.92099223 |
| 86 | cysteine metabolic process (GO:0006534) | 2.91073570 |
| 87 | amino acid salvage (GO:0043102) | 2.89796365 |
| 88 | L-methionine salvage (GO:0071267) | 2.89796365 |
| 89 | L-methionine biosynthetic process (GO:0071265) | 2.89796365 |
| 90 | serine family amino acid metabolic process (GO:0009069) | 2.89723407 |
| 91 | DNA replication initiation (GO:0006270) | 2.87741432 |
| 92 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.86580374 |
| 93 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.86359627 |
| 94 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.86358929 |
| 95 | pentose metabolic process (GO:0019321) | 2.85226628 |
| 96 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.83534006 |
| 97 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.81577844 |
| 98 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.81193719 |
| 99 | regulation of mitochondrial translation (GO:0070129) | 2.80859751 |
| 100 | COPI coating of Golgi vesicle (GO:0048205) | 2.80798982 |
| 101 | Golgi transport vesicle coating (GO:0048200) | 2.80798982 |
| 102 | telomere maintenance via telomere lengthening (GO:0010833) | 2.80321913 |
| 103 | protein targeting to membrane (GO:0006612) | 2.80221496 |
| 104 | platelet dense granule organization (GO:0060155) | 2.77083519 |
| 105 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.76733949 |
| 106 | termination of RNA polymerase III transcription (GO:0006386) | 2.76733949 |
| 107 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.75495821 |
| 108 | regulation of chromatin binding (GO:0035561) | 2.74774242 |
| 109 | cellular component biogenesis (GO:0044085) | 2.73356081 |
| 110 | urea metabolic process (GO:0019627) | 2.72491197 |
| 111 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.72204082 |
| 112 | motile cilium assembly (GO:0044458) | 2.70331209 |
| 113 | amyloid precursor protein catabolic process (GO:0042987) | 2.69936230 |
| 114 | mitochondrial fusion (GO:0008053) | 2.68830408 |
| 115 | nitrogen cycle metabolic process (GO:0071941) | 2.68639273 |
| 116 | tryptophan metabolic process (GO:0006568) | 2.68284478 |
| 117 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.66822354 |
| 118 | inner mitochondrial membrane organization (GO:0007007) | 2.66134035 |
| 119 | amino-acid betaine metabolic process (GO:0006577) | 2.66045832 |
| 120 | snRNA metabolic process (GO:0016073) | 2.65655553 |
| 121 | drug transport (GO:0015893) | 2.65510707 |
| 122 | cellular biogenic amine catabolic process (GO:0042402) | 2.65508560 |
| 123 | amine catabolic process (GO:0009310) | 2.65508560 |
| 124 | lipopolysaccharide metabolic process (GO:0008653) | 2.64974799 |
| 125 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.64679470 |
| 126 | drug transmembrane transport (GO:0006855) | 2.64575815 |
| 127 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.63179944 |
| 128 | lymphoid progenitor cell differentiation (GO:0002320) | 2.62747155 |
| 129 | positive regulation of histone deacetylation (GO:0031065) | 2.62723200 |
| 130 | adenosine receptor signaling pathway (GO:0001973) | 2.62680236 |
| 131 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.62662615 |
| 132 | mRNA catabolic process (GO:0006402) | 2.62661886 |
| 133 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.61517746 |
| 134 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.61131833 |
| 135 | negative regulation of cell killing (GO:0031342) | 2.61131833 |
| 136 | pinocytosis (GO:0006907) | 2.59978237 |
| 137 | rRNA processing (GO:0006364) | 2.59926951 |
| 138 | ubiquinone biosynthetic process (GO:0006744) | 2.58717114 |
| 139 | quinone biosynthetic process (GO:1901663) | 2.58717114 |
| 140 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.58045317 |
| 141 | regulation of defense response to virus by virus (GO:0050690) | 2.57721013 |
| 142 | mitotic recombination (GO:0006312) | 2.57183063 |
| 143 | regulation of superoxide anion generation (GO:0032928) | 2.57173139 |
| 144 | response to peptidoglycan (GO:0032494) | 2.56917619 |
| 145 | response to laminar fluid shear stress (GO:0034616) | 2.56656357 |
| 146 | regulation of extracellular matrix disassembly (GO:0010715) | 2.56191557 |
| 147 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.56084603 |
| 148 | tRNA methylation (GO:0030488) | 2.55043109 |
| 149 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.54974271 |
| 150 | CTP metabolic process (GO:0046036) | 2.53152067 |
| 151 | CTP biosynthetic process (GO:0006241) | 2.53152067 |
| 152 | rRNA metabolic process (GO:0016072) | 2.53034679 |
| 153 | stress fiber assembly (GO:0043149) | 2.52694953 |
| 154 | apoptotic process involved in morphogenesis (GO:0060561) | 2.51222312 |
| 155 | heme metabolic process (GO:0042168) | 2.50920671 |
| 156 | bile acid biosynthetic process (GO:0006699) | 2.50150232 |
| 157 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.49861471 |
| 158 | proline metabolic process (GO:0006560) | 2.47080575 |
| 159 | establishment of protein localization to membrane (GO:0090150) | 2.47028489 |
| 160 | RNA catabolic process (GO:0006401) | 2.46998148 |
| 161 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.46746808 |
| 162 | serine family amino acid catabolic process (GO:0009071) | 2.46722599 |
| 163 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.46640406 |
| 164 | low-density lipoprotein particle clearance (GO:0034383) | 2.46254142 |
| 165 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.46233986 |
| 166 | pyrimidine nucleoside biosynthetic process (GO:0046134) | 2.45588183 |
| 167 | pteridine-containing compound metabolic process (GO:0042558) | 2.45027634 |
| 168 | positive regulation of protein deacetylation (GO:0090312) | 2.44470878 |
| 169 | embryonic body morphogenesis (GO:0010172) | 2.44037855 |
| 170 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 2.42877655 |
| 171 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.41868296 |
| 172 | pentose-phosphate shunt (GO:0006098) | 2.40789392 |
| 173 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.40655669 |
| 174 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.39317712 |
| 175 | regulation of histone deacetylation (GO:0031063) | 2.35779599 |
| 176 | activation of MAPKKK activity (GO:0000185) | 2.35775284 |
| 177 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.34883963 |
| 178 | detection of other organism (GO:0098543) | 2.32208529 |
| 179 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.32182085 |
| 180 | heterochromatin organization (GO:0070828) | 2.31294726 |
| 181 | response to parathyroid hormone (GO:0071107) | 2.29938078 |
| 182 | negative regulation of fibrinolysis (GO:0051918) | 2.27395555 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.00512962 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.91315324 |
| 3 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.85571081 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.65533079 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.62601247 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.60880256 |
| 7 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.34658198 |
| 8 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.28242920 |
| 9 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.25003148 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.24708037 |
| 11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.19603025 |
| 12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.07451315 |
| 13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.03676808 |
| 14 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.98507381 |
| 15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.94252590 |
| 16 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.86121800 |
| 17 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.76218081 |
| 18 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.68252643 |
| 19 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.68133330 |
| 20 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.59499980 |
| 21 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.58523920 |
| 22 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.50827312 |
| 23 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.43931767 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.43271463 |
| 25 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.40955858 |
| 26 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.34629376 |
| 27 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.33644026 |
| 28 | MYC_22102868_ChIP-Seq_BL_Human | 2.30000884 |
| 29 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.22316424 |
| 30 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.21435452 |
| 31 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.20365846 |
| 32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.18173691 |
| 33 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.16357887 |
| 34 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.15932710 |
| 35 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.10318868 |
| 36 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.10063179 |
| 37 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.09718513 |
| 38 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.09190115 |
| 39 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.04793288 |
| 40 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.04774938 |
| 41 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.95907044 |
| 42 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.95799519 |
| 43 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.95126418 |
| 44 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.94889795 |
| 45 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.94702928 |
| 46 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.92529442 |
| 47 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89374888 |
| 48 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.87687241 |
| 49 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.86754068 |
| 50 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.86215211 |
| 51 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.84072993 |
| 52 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.82599988 |
| 53 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.82451876 |
| 54 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.82016069 |
| 55 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.81546979 |
| 56 | * MAF_26560356_Chip-Seq_TH1_Human | 1.80616695 |
| 57 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.79728435 |
| 58 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.77869901 |
| 59 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.77474360 |
| 60 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.76918710 |
| 61 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.76511693 |
| 62 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.75410861 |
| 63 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.72631520 |
| 64 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.72346642 |
| 65 | MAF_26560356_Chip-Seq_TH2_Human | 1.68668063 |
| 66 | P68_20966046_ChIP-Seq_HELA_Human | 1.68426598 |
| 67 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.66573230 |
| 68 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.63237436 |
| 69 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.63097708 |
| 70 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.58929627 |
| 71 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.58727858 |
| 72 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57510557 |
| 73 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.53116426 |
| 74 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.52425653 |
| 75 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.51891308 |
| 76 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.49654709 |
| 77 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.49323340 |
| 78 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48299585 |
| 79 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.47496638 |
| 80 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.47374037 |
| 81 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.46000517 |
| 82 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.45903893 |
| 83 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.45519227 |
| 84 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.45130186 |
| 85 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.43986249 |
| 86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.43263222 |
| 87 | KDM2B_26808549_Chip-Seq_K562_Human | 1.41027270 |
| 88 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.38768977 |
| 89 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.37013917 |
| 90 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.36494070 |
| 91 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.35726612 |
| 92 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.35237696 |
| 93 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.33431726 |
| 94 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.32893307 |
| 95 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.32698502 |
| 96 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.32691336 |
| 97 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.32143139 |
| 98 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.31814805 |
| 99 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.30657836 |
| 100 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.30413141 |
| 101 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30156244 |
| 102 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.29705760 |
| 103 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.29594194 |
| 104 | ATF3_27146783_Chip-Seq_COLON_Human | 1.28408554 |
| 105 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28027425 |
| 106 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.26469698 |
| 107 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.25575775 |
| 108 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25326821 |
| 109 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.23704337 |
| 110 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.23657508 |
| 111 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23062364 |
| 112 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.22855633 |
| 113 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.22650836 |
| 114 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.22615576 |
| 115 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.22383550 |
| 116 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.22144691 |
| 117 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.21542413 |
| 118 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.21033640 |
| 119 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.20884635 |
| 120 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20850187 |
| 121 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19669869 |
| 122 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.19002830 |
| 123 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.18935742 |
| 124 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.18917178 |
| 125 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.18710267 |
| 126 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.18023956 |
| 127 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17987107 |
| 128 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.16584229 |
| 129 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.16478532 |
| 130 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.16472757 |
| 131 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.15717659 |
| 132 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.15544812 |
| 133 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15518934 |
| 134 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15408121 |
| 135 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.15000378 |
| 136 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.14798897 |
| 137 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13525019 |
| 138 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10636416 |
| 139 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.09887919 |
| 140 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.08513312 |
| 141 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.08391010 |
| 142 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07032157 |
| 143 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.06883019 |
| 144 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.06237162 |
| 145 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.06114240 |
| 146 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.04692611 |
| 147 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.03602988 |
| 148 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.03213015 |
| 149 | SA1_27219007_Chip-Seq_Bcells_Human | 1.02682744 |
| 150 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.01853070 |
| 151 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.00778946 |
| 152 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.00306438 |
| 153 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99866065 |
| 154 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99102149 |
| 155 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94797052 |
| 156 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.94632448 |
| 157 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.91934157 |
| 158 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.89039775 |
| 159 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.88890155 |
| 160 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.87949365 |
| 161 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.84832480 |
| 162 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.81851018 |
| 163 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.81454419 |
| 164 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.81134185 |
| 165 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.80717531 |
| 166 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80320256 |
| 167 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.80244742 |
| 168 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.78340561 |
| 169 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.77949679 |
| 170 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.76454771 |
| 171 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.75695500 |
| 172 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.75509319 |
| 173 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.74280675 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.90570551 |
| 2 | MP0005360_urolithiasis | 4.10309691 |
| 3 | MP0003123_paternal_imprinting | 3.68227034 |
| 4 | MP0005365_abnormal_bile_salt | 3.55146638 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.36513376 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.33121032 |
| 7 | MP0005058_abnormal_lysosome_morphology | 3.17862939 |
| 8 | MP0009379_abnormal_foot_pigmentation | 3.14035362 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.86189236 |
| 10 | MP0003693_abnormal_embryo_hatching | 2.66818616 |
| 11 | MP0003303_peritoneal_inflammation | 2.59073075 |
| 12 | MP0002877_abnormal_melanocyte_morpholog | 2.56890763 |
| 13 | MP0002396_abnormal_hematopoietic_system | 2.47437925 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.39725499 |
| 15 | MP0008057_abnormal_DNA_replication | 2.34009064 |
| 16 | MP0004147_increased_porphyrin_level | 2.21753121 |
| 17 | MP0003656_abnormal_erythrocyte_physiolo | 2.14579858 |
| 18 | MP0002132_abnormal_respiratory_system | 2.11275013 |
| 19 | MP0001764_abnormal_homeostasis | 2.10887308 |
| 20 | MP0005075_abnormal_melanosome_morpholog | 2.07676398 |
| 21 | MP0009840_abnormal_foam_cell | 2.06453453 |
| 22 | MP0006292_abnormal_olfactory_placode | 2.06286791 |
| 23 | MP0003172_abnormal_lysosome_physiology | 2.03824653 |
| 24 | MP0002102_abnormal_ear_morphology | 2.02366785 |
| 25 | MP0008260_abnormal_autophagy | 2.01987948 |
| 26 | MP0003186_abnormal_redox_activity | 1.95607046 |
| 27 | MP0003724_increased_susceptibility_to | 1.94392963 |
| 28 | MP0005332_abnormal_amino_acid | 1.90207072 |
| 29 | MP0003453_abnormal_keratinocyte_physiol | 1.89796225 |
| 30 | MP0001666_abnormal_nutrient_absorption | 1.85243107 |
| 31 | MP0005174_abnormal_tail_pigmentation | 1.85092188 |
| 32 | MP0006036_abnormal_mitochondrial_physio | 1.81198200 |
| 33 | MP0008058_abnormal_DNA_repair | 1.80169619 |
| 34 | MP0002822_catalepsy | 1.79638026 |
| 35 | MP0003252_abnormal_bile_duct | 1.76486685 |
| 36 | MP0000685_abnormal_immune_system | 1.76293740 |
| 37 | MP0003868_abnormal_feces_composition | 1.73676923 |
| 38 | MP0005084_abnormal_gallbladder_morpholo | 1.72070797 |
| 39 | MP0005083_abnormal_biliary_tract | 1.70784023 |
| 40 | MP0003195_calcinosis | 1.66586468 |
| 41 | MP0003136_yellow_coat_color | 1.64528079 |
| 42 | MP0010094_abnormal_chromosome_stability | 1.64108670 |
| 43 | MP0005220_abnormal_exocrine_pancreas | 1.63226496 |
| 44 | MP0003879_abnormal_hair_cell | 1.62303172 |
| 45 | MP0000858_altered_metastatic_potential | 1.61183226 |
| 46 | MP0003111_abnormal_nucleus_morphology | 1.58015346 |
| 47 | MP0002089_abnormal_postnatal_growth/wei | 1.56518075 |
| 48 | MP0004019_abnormal_vitamin_homeostasis | 1.55007942 |
| 49 | MP0003300_gastrointestinal_ulcer | 1.53906314 |
| 50 | MP0000490_abnormal_crypts_of | 1.50892546 |
| 51 | MP0010329_abnormal_lipoprotein_level | 1.50783470 |
| 52 | MP0001986_abnormal_taste_sensitivity | 1.48260582 |
| 53 | MP0005076_abnormal_cell_differentiation | 1.46518963 |
| 54 | MP0005636_abnormal_mineral_homeostasis | 1.40185256 |
| 55 | MP0005409_darkened_coat_color | 1.39530940 |
| 56 | MP0004947_skin_inflammation | 1.37400901 |
| 57 | MP0002653_abnormal_ependyma_morphology | 1.36623992 |
| 58 | MP0001849_ear_inflammation | 1.35413515 |
| 59 | MP0000465_gastrointestinal_hemorrhage | 1.32697488 |
| 60 | MP0000678_abnormal_parathyroid_gland | 1.32393423 |
| 61 | MP0004858_abnormal_nervous_system | 1.32079410 |
| 62 | MP0005451_abnormal_body_composition | 1.31602987 |
| 63 | MP0001545_abnormal_hematopoietic_system | 1.28968926 |
| 64 | MP0005397_hematopoietic_system_phenotyp | 1.28968926 |
| 65 | MP0004957_abnormal_blastocyst_morpholog | 1.28709383 |
| 66 | MP0001348_abnormal_lacrimal_gland | 1.28076228 |
| 67 | MP0005666_abnormal_adipose_tissue | 1.26354368 |
| 68 | MP0009785_altered_susceptibility_to | 1.25201863 |
| 69 | MP0001790_abnormal_immune_system | 1.25184680 |
| 70 | MP0005387_immune_system_phenotype | 1.25184680 |
| 71 | MP0004381_abnormal_hair_follicle | 1.24760267 |
| 72 | MP0004185_abnormal_adipocyte_glucose | 1.23931874 |
| 73 | MP0005319_abnormal_enzyme/_coenzyme | 1.22959947 |
| 74 | MP0005464_abnormal_platelet_physiology | 1.22513612 |
| 75 | MP0010234_abnormal_vibrissa_follicle | 1.22343482 |
| 76 | MP0006035_abnormal_mitochondrial_morpho | 1.20413831 |
| 77 | MP0008469_abnormal_protein_level | 1.20267468 |
| 78 | MP0009333_abnormal_splenocyte_physiolog | 1.19397143 |
| 79 | MP0002138_abnormal_hepatobiliary_system | 1.18793761 |
| 80 | MP0004510_myositis | 1.16969030 |
| 81 | MP0005375_adipose_tissue_phenotype | 1.16131806 |
| 82 | MP0005501_abnormal_skin_physiology | 1.14439211 |
| 83 | MP0005025_abnormal_response_to | 1.14149595 |
| 84 | MP0001533_abnormal_skeleton_physiology | 1.13533525 |
| 85 | MP0008007_abnormal_cellular_replicative | 1.13234059 |
| 86 | MP0009643_abnormal_urine_homeostasis | 1.13029819 |
| 87 | MP0001188_hyperpigmentation | 1.11312378 |
| 88 | MP0004233_abnormal_muscle_weight | 1.10820459 |
| 89 | MP0000604_amyloidosis | 1.10271802 |
| 90 | MP0003077_abnormal_cell_cycle | 1.10011563 |
| 91 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.09725888 |
| 92 | MP0003183_abnormal_peptide_metabolism | 1.09234349 |
| 93 | MP0000003_abnormal_adipose_tissue | 1.09162893 |
| 94 | MP0003566_abnormal_cell_adhesion | 1.08028707 |
| 95 | MP0003329_amyloid_beta_deposits | 1.07741293 |
| 96 | MP0005257_abnormal_intraocular_pressure | 1.06337824 |
| 97 | MP0002095_abnormal_skin_pigmentation | 1.05525433 |
| 98 | MP0001835_abnormal_antigen_presentation | 1.05453069 |
| 99 | MP0003763_abnormal_thymus_physiology | 1.05251324 |
| 100 | MP0002452_abnormal_antigen_presenting | 1.04389606 |
| 101 | MP0000609_abnormal_liver_physiology | 1.02883420 |
| 102 | MP0002938_white_spotting | 1.01864725 |
| 103 | MP0000689_abnormal_spleen_morphology | 1.00722189 |
| 104 | MP0004264_abnormal_extraembryonic_tissu | 1.00578417 |
| 105 | MP0005000_abnormal_immune_tolerance | 0.99031005 |
| 106 | MP0001800_abnormal_humoral_immune | 0.98928366 |
| 107 | MP0003191_abnormal_cellular_cholesterol | 0.98838490 |
| 108 | MP0005670_abnormal_white_adipose | 0.98479721 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.97368506 |
| 110 | MP0005671_abnormal_response_to | 0.96495742 |
| 111 | MP0009053_abnormal_anal_canal | 0.95888588 |
| 112 | MP0002722_abnormal_immune_system | 0.93305935 |
| 113 | MP0010155_abnormal_intestine_physiology | 0.93105731 |
| 114 | MP0000750_abnormal_muscle_regeneration | 0.92846238 |
| 115 | MP0002118_abnormal_lipid_homeostasis | 0.92325923 |
| 116 | MP0002398_abnormal_bone_marrow | 0.92170218 |
| 117 | MP0002796_impaired_skin_barrier | 0.90986070 |
| 118 | MP0010030_abnormal_orbit_morphology | 0.90919561 |
| 119 | MP0002429_abnormal_blood_cell | 0.90681649 |
| 120 | MP0009763_increased_sensitivity_to | 0.90579663 |
| 121 | MP0003436_decreased_susceptibility_to | 0.90081608 |
| 122 | MP0001845_abnormal_inflammatory_respons | 0.87942596 |
| 123 | MP0001663_abnormal_digestive_system | 0.87594620 |
| 124 | MP0000716_abnormal_immune_system | 0.86535545 |
| 125 | MP0003718_maternal_effect | 0.86291578 |
| 126 | MP0003866_abnormal_defecation | 0.86173202 |
| 127 | MP0002876_abnormal_thyroid_physiology | 0.85509788 |
| 128 | MP0002419_abnormal_innate_immunity | 0.84991649 |
| 129 | MP0003075_altered_response_to | 0.84730472 |
| 130 | MP0001853_heart_inflammation | 0.84720077 |
| 131 | MP0000015_abnormal_ear_pigmentation | 0.83978814 |
| 132 | MP0003091_abnormal_cell_migration | 0.82579557 |
| 133 | MP0003011_delayed_dark_adaptation | 0.82540879 |
| 134 | MP0003315_abnormal_perineum_morphology | 0.81515769 |
| 135 | MP0004808_abnormal_hematopoietic_stem | 0.81365220 |
| 136 | MP0001873_stomach_inflammation | 0.78057279 |
| 137 | MP0002998_abnormal_bone_remodeling | 0.77959750 |
| 138 | MP0003786_premature_aging | 0.77721240 |
| 139 | MP0009642_abnormal_blood_homeostasis | 0.77071816 |
| 140 | MP0005381_digestive/alimentary_phenotyp | 0.76983602 |
| 141 | MP0002723_abnormal_immune_serum | 0.76587938 |
| 142 | MP0000598_abnormal_liver_morphology | 0.76156877 |
| 143 | MP0004142_abnormal_muscle_tone | 0.76143835 |
| 144 | MP0009931_abnormal_skin_appearance | 0.76092728 |
| 145 | MP0001485_abnormal_pinna_reflex | 0.75965951 |
| 146 | MP0002420_abnormal_adaptive_immunity | 0.75893247 |
| 147 | MP0005379_endocrine/exocrine_gland_phen | 0.75478687 |
| 148 | MP0008877_abnormal_DNA_methylation | 0.74431918 |
| 149 | MP0008932_abnormal_embryonic_tissue | 0.74146238 |
| 150 | MP0001756_abnormal_urination | 0.74111631 |
| 151 | MP0009764_decreased_sensitivity_to | 0.73890324 |
| 152 | MP0008874_decreased_physiological_sensi | 0.73655674 |
| 153 | MP0001819_abnormal_immune_cell | 0.73631770 |
| 154 | MP0000343_altered_response_to | 0.73377373 |
| 155 | MP0002019_abnormal_tumor_incidence | 0.73282441 |
| 156 | MP0000703_abnormal_thymus_morphology | 0.71679959 |
| 157 | MP0009697_abnormal_copulation | 0.70534894 |
| 158 | MP0003959_abnormal_lean_body | 0.69389384 |
| 159 | MP0002136_abnormal_kidney_physiology | 0.68659311 |
| 160 | MP0001216_abnormal_epidermal_layer | 0.68145683 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal number of erythroid precursors (HP:0012131) | 4.83506887 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.76770803 |
| 3 | Reticulocytopenia (HP:0001896) | 4.52653469 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.12845327 |
| 5 | Reduced antithrombin III activity (HP:0001976) | 4.02941718 |
| 6 | Aplastic anemia (HP:0001915) | 3.98110897 |
| 7 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.87025026 |
| 8 | Hyperparathyroidism (HP:0000843) | 3.64135008 |
| 9 | Macrocytic anemia (HP:0001972) | 3.47052106 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 3.42454232 |
| 11 | Type I transferrin isoform profile (HP:0003642) | 3.32360891 |
| 12 | Vertebral compression fractures (HP:0002953) | 3.28054986 |
| 13 | Purpura (HP:0000979) | 3.24253483 |
| 14 | Pallor (HP:0000980) | 3.22436832 |
| 15 | Abnormality of macrophages (HP:0004311) | 3.10028836 |
| 16 | Intrahepatic cholestasis (HP:0001406) | 3.09246621 |
| 17 | Hemorrhage of the eye (HP:0011885) | 3.05941336 |
| 18 | Poikiloderma (HP:0001029) | 3.04543942 |
| 19 | Entropion (HP:0000621) | 3.02672154 |
| 20 | Hepatic necrosis (HP:0002605) | 3.02610584 |
| 21 | Nasal polyposis (HP:0100582) | 3.01952524 |
| 22 | Thin bony cortex (HP:0002753) | 2.99134844 |
| 23 | Mitochondrial inheritance (HP:0001427) | 2.95135045 |
| 24 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.93020973 |
| 25 | Acute encephalopathy (HP:0006846) | 2.92190472 |
| 26 | Eczematoid dermatitis (HP:0000976) | 2.88709236 |
| 27 | Acute necrotizing encephalopathy (HP:0006965) | 2.87412954 |
| 28 | Dicarboxylic aciduria (HP:0003215) | 2.87156405 |
| 29 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.87156405 |
| 30 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.86391016 |
| 31 | Hepatocellular necrosis (HP:0001404) | 2.86302166 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 2.85048113 |
| 33 | Abnormal protein glycosylation (HP:0012346) | 2.84541774 |
| 34 | Abnormal glycosylation (HP:0012345) | 2.84541774 |
| 35 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.84541774 |
| 36 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.84541774 |
| 37 | Recurrent bacterial skin infections (HP:0005406) | 2.84039617 |
| 38 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.77060127 |
| 39 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.77060127 |
| 40 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.76900107 |
| 41 | Pancytopenia (HP:0001876) | 2.75156955 |
| 42 | Deep palmar crease (HP:0006191) | 2.74014973 |
| 43 | Delayed CNS myelination (HP:0002188) | 2.68266732 |
| 44 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.67681703 |
| 45 | Petechiae (HP:0000967) | 2.67280225 |
| 46 | Multiple lipomas (HP:0001012) | 2.66960358 |
| 47 | Increased CSF lactate (HP:0002490) | 2.66148441 |
| 48 | Recurrent abscess formation (HP:0002722) | 2.66075246 |
| 49 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.65815352 |
| 50 | Hyperbilirubinemia (HP:0002904) | 2.64223124 |
| 51 | Opisthotonus (HP:0002179) | 2.62645647 |
| 52 | Cerebral edema (HP:0002181) | 2.60478278 |
| 53 | Increased serum lactate (HP:0002151) | 2.60277710 |
| 54 | Abnormality of the nasal mucosa (HP:0000433) | 2.59106322 |
| 55 | Generalized aminoaciduria (HP:0002909) | 2.57354181 |
| 56 | Thrombocytosis (HP:0001894) | 2.54875226 |
| 57 | Oral leukoplakia (HP:0002745) | 2.54204361 |
| 58 | 3-Methylglutaconic aciduria (HP:0003535) | 2.53860023 |
| 59 | Lipid accumulation in hepatocytes (HP:0006561) | 2.49764750 |
| 60 | Hypobetalipoproteinemia (HP:0003563) | 2.48759794 |
| 61 | Renal Fanconi syndrome (HP:0001994) | 2.48512474 |
| 62 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.46824024 |
| 63 | Abnormality of the Achilles tendon (HP:0005109) | 2.45482338 |
| 64 | Joint hemorrhage (HP:0005261) | 2.44571790 |
| 65 | Lactic acidosis (HP:0003128) | 2.43768038 |
| 66 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.43228747 |
| 67 | Increased hepatocellular lipid droplets (HP:0006565) | 2.41708381 |
| 68 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.41272589 |
| 69 | Lethargy (HP:0001254) | 2.39232741 |
| 70 | Hyperthyroidism (HP:0000836) | 2.38722678 |
| 71 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.37588517 |
| 72 | Abnormality of methionine metabolism (HP:0010901) | 2.36872211 |
| 73 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.36754225 |
| 74 | Microvesicular hepatic steatosis (HP:0001414) | 2.36637806 |
| 75 | Long palpebral fissure (HP:0000637) | 2.32973430 |
| 76 | Achilles tendon contracture (HP:0001771) | 2.30662508 |
| 77 | Increased intramyocellular lipid droplets (HP:0012240) | 2.29940683 |
| 78 | Cellulitis (HP:0100658) | 2.29295589 |
| 79 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.28810049 |
| 80 | Abnormality of serum amino acid levels (HP:0003112) | 2.27646732 |
| 81 | Chronic otitis media (HP:0000389) | 2.27218949 |
| 82 | Dysostosis multiplex (HP:0000943) | 2.27190538 |
| 83 | Hyperglycinemia (HP:0002154) | 2.25122997 |
| 84 | Neonatal hypoglycemia (HP:0001998) | 2.24343949 |
| 85 | Increased muscle lipid content (HP:0009058) | 2.23825186 |
| 86 | Protrusio acetabuli (HP:0003179) | 2.23504742 |
| 87 | Hyperammonemia (HP:0001987) | 2.22962046 |
| 88 | Epistaxis (HP:0000421) | 2.22173768 |
| 89 | Prolonged bleeding time (HP:0003010) | 2.21886816 |
| 90 | Hypercortisolism (HP:0001578) | 2.20947148 |
| 91 | Microcytic anemia (HP:0001935) | 2.19090893 |
| 92 | Megaloblastic anemia (HP:0001889) | 2.18307115 |
| 93 | Abnormality of glycine metabolism (HP:0010895) | 2.17888609 |
| 94 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.17888609 |
| 95 | Progressive macrocephaly (HP:0004481) | 2.17296344 |
| 96 | Ketosis (HP:0001946) | 2.16891466 |
| 97 | Increased cerebral lipofuscin (HP:0011813) | 2.16817265 |
| 98 | IgM deficiency (HP:0002850) | 2.16533773 |
| 99 | Hyperglycinuria (HP:0003108) | 2.14001177 |
| 100 | Chronic obstructive pulmonary disease (HP:0006510) | 2.13077152 |
| 101 | Obstructive lung disease (HP:0006536) | 2.13077152 |
| 102 | Abnormality of urine glucose concentration (HP:0011016) | 2.11567124 |
| 103 | Glycosuria (HP:0003076) | 2.11567124 |
| 104 | Hypoglycemic coma (HP:0001325) | 2.10337137 |
| 105 | Xanthomatosis (HP:0000991) | 2.10108555 |
| 106 | Atelectasis (HP:0100750) | 2.08951546 |
| 107 | Vacuolated lymphocytes (HP:0001922) | 2.08222543 |
| 108 | Abnormality of reticulocytes (HP:0004312) | 2.07641111 |
| 109 | Methylmalonic aciduria (HP:0012120) | 2.06457103 |
| 110 | Hypercalcemia (HP:0003072) | 2.06353021 |
| 111 | Flat acetabular roof (HP:0003180) | 2.05253670 |
| 112 | Abnormality of the thoracic spine (HP:0100711) | 2.04365291 |
| 113 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.03731394 |
| 114 | Short nail (HP:0001799) | 2.03150181 |
| 115 | Hypertensive crisis (HP:0100735) | 2.02385031 |
| 116 | Thyroid-stimulating hormone excess (HP:0002925) | 2.01892931 |
| 117 | Hypophosphatemia (HP:0002148) | 1.99974002 |
| 118 | Prolonged neonatal jaundice (HP:0006579) | 1.99463293 |
| 119 | Neutropenia (HP:0001875) | 1.99431007 |
| 120 | Hypoplasia of the thymus (HP:0000778) | 1.98261051 |
| 121 | Pathologic fracture (HP:0002756) | 1.97744036 |
| 122 | Polygenic inheritance (HP:0010982) | 1.94822244 |
| 123 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.94005476 |
| 124 | Brushfield spots (HP:0001088) | 1.93395490 |
| 125 | Deep venous thrombosis (HP:0002625) | 1.93280580 |
| 126 | Metabolic acidosis (HP:0001942) | 1.92540984 |
| 127 | Acute lymphatic leukemia (HP:0006721) | 1.92057534 |
| 128 | Renal cortical cysts (HP:0000803) | 1.91524883 |
| 129 | Abnormality of the common coagulation pathway (HP:0010990) | 1.91420517 |
| 130 | Ulnar bowing (HP:0003031) | 1.90929020 |
| 131 | Generalized hyperpigmentation (HP:0007440) | 1.89924990 |
| 132 | Gastrointestinal stroma tumor (HP:0100723) | 1.89879538 |
| 133 | Mucopolysacchariduria (HP:0008155) | 1.88881336 |
| 134 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.88881336 |
| 135 | Abnormality of renal resorption (HP:0011038) | 1.88327428 |
| 136 | Severe visual impairment (HP:0001141) | 1.88039000 |
| 137 | Squamous cell carcinoma (HP:0002860) | 1.86776832 |
| 138 | Exertional dyspnea (HP:0002875) | 1.84557846 |
| 139 | Abnormality of alanine metabolism (HP:0010916) | 1.84407313 |
| 140 | Hyperalaninemia (HP:0003348) | 1.84407313 |
| 141 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.84407313 |
| 142 | Hyperacusis (HP:0010780) | 1.84315553 |
| 143 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.83255283 |
| 144 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.82216243 |
| 145 | Hypophosphatemic rickets (HP:0004912) | 1.82206444 |
| 146 | Abnormal trabecular bone morphology (HP:0100671) | 1.82047776 |
| 147 | Abnormality of DNA repair (HP:0003254) | 1.82009546 |
| 148 | Emphysema (HP:0002097) | 1.81982577 |
| 149 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.81280763 |
| 150 | Exercise intolerance (HP:0003546) | 1.81238872 |
| 151 | Short femoral neck (HP:0100864) | 1.80504141 |
| 152 | Acanthocytosis (HP:0001927) | 1.80468472 |
| 153 | Gingivitis (HP:0000230) | 1.79667007 |
| 154 | Elevated hepatic transaminases (HP:0002910) | 1.79297114 |
| 155 | Asplenia (HP:0001746) | 1.78782145 |
| 156 | Vascular calcification (HP:0004934) | 1.77486881 |
| 157 | Systemic lupus erythematosus (HP:0002725) | 1.77005765 |
| 158 | Gastrointestinal infarctions (HP:0005244) | 1.76132143 |
| 159 | Increased serum ferritin (HP:0003281) | 1.76121501 |
| 160 | Rickets (HP:0002748) | 1.75225000 |
| 161 | Male infertility (HP:0003251) | 1.75119394 |
| 162 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.74141840 |
| 163 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.74141840 |
| 164 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.74141840 |
| 165 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.73704659 |
| 166 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.72648408 |
| 167 | Obstructive sleep apnea (HP:0002870) | 1.72381420 |
| 168 | Bone pain (HP:0002653) | 1.71545349 |
| 169 | Thoracic kyphosis (HP:0002942) | 1.70382221 |
| 170 | Anomalous pulmonary venous return (HP:0010772) | 1.69903083 |
| 171 | Hypertriglyceridemia (HP:0002155) | 1.68968932 |
| 172 | Asymmetry of the thorax (HP:0001555) | 1.68161773 |
| 173 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.68104947 |
| 174 | Turricephaly (HP:0000262) | 1.67210847 |
| 175 | Neurofibrillary tangles (HP:0002185) | 1.66169953 |
| 176 | Menorrhagia (HP:0000132) | 1.65745852 |
| 177 | Progressive muscle weakness (HP:0003323) | 1.65653199 |
| 178 | Abnormality of the intrinsic pathway (HP:0010989) | 1.64088446 |
| 179 | Abnormality of the pulmonary veins (HP:0011718) | 1.62718251 |
| 180 | Cervical subluxation (HP:0003308) | 1.62487568 |
| 181 | Hypochromic anemia (HP:0001931) | 1.62361316 |
| 182 | Testicular neoplasm (HP:0010788) | 1.61465651 |
| 183 | Rough bone trabeculation (HP:0100670) | 1.61211245 |
| 184 | Gastrointestinal dysmotility (HP:0002579) | 1.61164630 |
| 185 | Menstrual irregularities (HP:0000858) | 1.60570234 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.73967227 |
| 2 | TRIB3 | 4.64355706 |
| 3 | * STK16 | 4.29688441 |
| 4 | TNIK | 3.47421369 |
| 5 | PRPF4B | 3.07208718 |
| 6 | TLK1 | 2.87770602 |
| 7 | BUB1 | 2.85087001 |
| 8 | ICK | 2.82175082 |
| 9 | BCKDK | 2.80430624 |
| 10 | EIF2AK1 | 2.68459769 |
| 11 | WEE1 | 2.67389006 |
| 12 | RIPK4 | 2.63924199 |
| 13 | SMG1 | 2.58819357 |
| 14 | PIM2 | 2.44198928 |
| 15 | SIK1 | 2.37198974 |
| 16 | VRK1 | 2.26134132 |
| 17 | KIT | 2.11218397 |
| 18 | TEC | 2.03639767 |
| 19 | MAP4K1 | 2.00362654 |
| 20 | EEF2K | 1.96677169 |
| 21 | CDK19 | 1.93667421 |
| 22 | BLK | 1.85295842 |
| 23 | DYRK3 | 1.83954399 |
| 24 | FLT3 | 1.80243822 |
| 25 | EIF2AK3 | 1.73829013 |
| 26 | TAOK3 | 1.68225374 |
| 27 | MKNK2 | 1.65739142 |
| 28 | IRAK4 | 1.62269913 |
| 29 | PKN2 | 1.59672662 |
| 30 | BTK | 1.59288237 |
| 31 | EPHA2 | 1.54612583 |
| 32 | ARAF | 1.52806140 |
| 33 | SRPK1 | 1.52426755 |
| 34 | MKNK1 | 1.52018033 |
| 35 | FGFR4 | 1.50113509 |
| 36 | CDK12 | 1.49620380 |
| 37 | KDR | 1.49565556 |
| 38 | TAOK2 | 1.47362683 |
| 39 | PTK6 | 1.40134006 |
| 40 | FES | 1.39140701 |
| 41 | PDPK1 | 1.37801470 |
| 42 | MAP3K1 | 1.36548577 |
| 43 | MAP3K11 | 1.35898071 |
| 44 | LRRK2 | 1.27392343 |
| 45 | MARK2 | 1.27107234 |
| 46 | MUSK | 1.20121432 |
| 47 | CSK | 1.19307712 |
| 48 | PRKD2 | 1.15838226 |
| 49 | EIF2AK2 | 1.14282914 |
| 50 | KSR2 | 1.12623688 |
| 51 | BRSK2 | 1.10693283 |
| 52 | CDK7 | 1.09812335 |
| 53 | TESK2 | 1.03232233 |
| 54 | EPHB1 | 1.02171520 |
| 55 | RIPK1 | 1.01935059 |
| 56 | TXK | 0.99561581 |
| 57 | MAPKAPK5 | 0.99146371 |
| 58 | TNK2 | 0.97789379 |
| 59 | DMPK | 0.97787085 |
| 60 | TAOK1 | 0.95513045 |
| 61 | RAF1 | 0.93696278 |
| 62 | MAPK15 | 0.93237047 |
| 63 | LYN | 0.92961225 |
| 64 | MAP3K3 | 0.90839838 |
| 65 | ACVR1B | 0.89883896 |
| 66 | IRAK3 | 0.89125842 |
| 67 | HIPK2 | 0.88627655 |
| 68 | MAP3K10 | 0.88406552 |
| 69 | ILK | 0.88007734 |
| 70 | CCNB1 | 0.87831517 |
| 71 | PDK1 | 0.86435474 |
| 72 | MAPK12 | 0.86355476 |
| 73 | TESK1 | 0.86145150 |
| 74 | NLK | 0.86127645 |
| 75 | MAPK4 | 0.85587422 |
| 76 | NUAK1 | 0.85093878 |
| 77 | MTOR | 0.84059060 |
| 78 | PASK | 0.83402347 |
| 79 | SYK | 0.82007281 |
| 80 | PIK3CG | 0.80614758 |
| 81 | BMX | 0.79193531 |
| 82 | CLK1 | 0.77439325 |
| 83 | PDK2 | 0.77283416 |
| 84 | MAP2K3 | 0.76727492 |
| 85 | MAP3K8 | 0.76507121 |
| 86 | AURKB | 0.75965209 |
| 87 | SIK2 | 0.75614704 |
| 88 | AURKA | 0.75522636 |
| 89 | RPS6KA4 | 0.74735518 |
| 90 | ADRBK2 | 0.74181385 |
| 91 | CDC42BPA | 0.72367764 |
| 92 | IRAK1 | 0.71788735 |
| 93 | MAP3K2 | 0.70983366 |
| 94 | RPS6KB2 | 0.70888913 |
| 95 | CDC7 | 0.70625650 |
| 96 | CSF1R | 0.70208488 |
| 97 | ZAP70 | 0.69619255 |
| 98 | YES1 | 0.68875702 |
| 99 | IRAK2 | 0.68578747 |
| 100 | IKBKE | 0.68262061 |
| 101 | ATR | 0.67512075 |
| 102 | RPS6KA2 | 0.67254044 |
| 103 | RPS6KC1 | 0.67110889 |
| 104 | RPS6KL1 | 0.67110889 |
| 105 | MAP3K9 | 0.66091529 |
| 106 | DDR2 | 0.65342444 |
| 107 | DAPK3 | 0.63735008 |
| 108 | PLK1 | 0.62737580 |
| 109 | ABL2 | 0.62250140 |
| 110 | TYK2 | 0.58663009 |
| 111 | MAPKAPK3 | 0.58081906 |
| 112 | CAMKK2 | 0.57973556 |
| 113 | TIE1 | 0.57959403 |
| 114 | CSNK2A1 | 0.56850238 |
| 115 | PAK4 | 0.56728973 |
| 116 | TGFBR1 | 0.56068192 |
| 117 | ERN1 | 0.55732050 |
| 118 | CSNK2A2 | 0.55682632 |
| 119 | TBK1 | 0.55073254 |
| 120 | INSRR | 0.54741801 |
| 121 | CSNK1G3 | 0.54385773 |
| 122 | MAPK11 | 0.54162420 |
| 123 | CDK4 | 0.53249237 |
| 124 | MAP2K7 | 0.52724102 |
| 125 | SCYL2 | 0.52576484 |
| 126 | BRAF | 0.52526951 |
| 127 | NEK2 | 0.52246239 |
| 128 | RPS6KA6 | 0.52200544 |
| 129 | NME1 | 0.52175654 |
| 130 | MAP2K6 | 0.50112729 |
| 131 | RPS6KA5 | 0.49952103 |
| 132 | TYRO3 | 0.49666000 |
| 133 | MAPK13 | 0.49500198 |
| 134 | LCK | 0.49103561 |
| 135 | PDGFRA | 0.48139222 |
| 136 | RET | 0.48112477 |
| 137 | WNK3 | 0.47422365 |
| 138 | CAMKK1 | 0.45814121 |
| 139 | JAK2 | 0.43492157 |
| 140 | MAP3K12 | 0.43439585 |
| 141 | OXSR1 | 0.43414764 |
| 142 | ZAK | 0.41675443 |
| 143 | CAMK1 | 0.41127295 |
| 144 | PINK1 | 0.41103478 |
| 145 | MAP2K2 | 0.40938644 |
| 146 | IKBKB | 0.40869655 |
| 147 | GRK1 | 0.40852045 |
| 148 | DYRK2 | 0.40610965 |
| 149 | DYRK1B | 0.40548933 |
| 150 | PAK1 | 0.39980612 |
| 151 | MAPK7 | 0.39886930 |
| 152 | NEK9 | 0.38863748 |
| 153 | CSNK1G1 | 0.37679356 |
| 154 | FGFR3 | 0.36867703 |
| 155 | MST1R | 0.35119400 |
| 156 | MATK | 0.34986416 |
| 157 | STK24 | 0.34041705 |
| 158 | MAP3K14 | 0.33960125 |
| 159 | CDK3 | 0.33848616 |
| 160 | GRK6 | 0.33427315 |
| 161 | PLK4 | 0.32452668 |
| 162 | PTK2 | 0.32194635 |
| 163 | RPS6KA1 | 0.32135335 |
| 164 | AKT2 | 0.32032649 |
| 165 | STK4 | 0.31793314 |
| 166 | CAMK1D | 0.31787992 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.02250234 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.19860185 |
| 3 | Protein export_Homo sapiens_hsa03060 | 2.62631217 |
| 4 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.49611581 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.46542864 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.27153784 |
| 7 | VEGF signaling pathway_Homo sapiens_hsa04370 | 2.20965144 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.15927217 |
| 9 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 2.15632533 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.14899765 |
| 11 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.13189848 |
| 12 | Mismatch repair_Homo sapiens_hsa03430 | 2.10485309 |
| 13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.10301386 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 2.06740972 |
| 15 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.05831170 |
| 16 | RNA polymerase_Homo sapiens_hsa03020 | 2.03979932 |
| 17 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.95988908 |
| 18 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.95331330 |
| 19 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.91656835 |
| 20 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.90814128 |
| 21 | Sulfur relay system_Homo sapiens_hsa04122 | 1.89002248 |
| 22 | Proteasome_Homo sapiens_hsa03050 | 1.87300558 |
| 23 | Bladder cancer_Homo sapiens_hsa05219 | 1.84353302 |
| 24 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.78049562 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.76804018 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.71086989 |
| 27 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.68646463 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.67359884 |
| 29 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.64898678 |
| 30 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.64713253 |
| 31 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.62701226 |
| 32 | Base excision repair_Homo sapiens_hsa03410 | 1.61611612 |
| 33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.59091737 |
| 34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.58797544 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.56984287 |
| 36 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.56717325 |
| 37 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.56275754 |
| 38 | Endometrial cancer_Homo sapiens_hsa05213 | 1.53438576 |
| 39 | Spliceosome_Homo sapiens_hsa03040 | 1.52598687 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.51402392 |
| 41 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.49214535 |
| 42 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.49167005 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.48228469 |
| 44 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.48152031 |
| 45 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.45300538 |
| 46 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.44676221 |
| 47 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.44057418 |
| 48 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.43714466 |
| 49 | Histidine metabolism_Homo sapiens_hsa00340 | 1.35484232 |
| 50 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.34143746 |
| 51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.31433638 |
| 52 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.29857627 |
| 53 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.28146589 |
| 54 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27820452 |
| 55 | Alcoholism_Homo sapiens_hsa05034 | 1.27436096 |
| 56 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.26656015 |
| 57 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.26354713 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.26151045 |
| 59 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.25280349 |
| 60 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.24228605 |
| 61 | Hepatitis C_Homo sapiens_hsa05160 | 1.23182438 |
| 62 | Parkinsons disease_Homo sapiens_hsa05012 | 1.23050813 |
| 63 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.20966055 |
| 64 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.20696985 |
| 65 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.20671460 |
| 66 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.20623471 |
| 67 | Prion diseases_Homo sapiens_hsa05020 | 1.19268753 |
| 68 | Thyroid cancer_Homo sapiens_hsa05216 | 1.18607591 |
| 69 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.18561768 |
| 70 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.17418888 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 1.15365436 |
| 72 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.14915153 |
| 73 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.14866756 |
| 74 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.13459352 |
| 75 | Retinol metabolism_Homo sapiens_hsa00830 | 1.12365951 |
| 76 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.11579608 |
| 77 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.09333853 |
| 78 | Purine metabolism_Homo sapiens_hsa00230 | 1.06936549 |
| 79 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.04078136 |
| 80 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.03442679 |
| 81 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.03178997 |
| 82 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02471255 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.02079798 |
| 84 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.00556392 |
| 85 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.00516558 |
| 86 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.00109026 |
| 87 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.99411671 |
| 88 | Apoptosis_Homo sapiens_hsa04210 | 0.99006902 |
| 89 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97448738 |
| 90 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.97288522 |
| 91 | ABC transporters_Homo sapiens_hsa02010 | 0.95245591 |
| 92 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.94226601 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.91772909 |
| 94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91128112 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.90789303 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.89150973 |
| 97 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.87072186 |
| 98 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.86856258 |
| 99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86848682 |
| 100 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.86354000 |
| 101 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.86070610 |
| 102 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.84976246 |
| 103 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.84946524 |
| 104 | Leishmaniasis_Homo sapiens_hsa05140 | 0.84918799 |
| 105 | Hepatitis B_Homo sapiens_hsa05161 | 0.84808398 |
| 106 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.84072459 |
| 107 | Glioma_Homo sapiens_hsa05214 | 0.83628852 |
| 108 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.83258663 |
| 109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.82733927 |
| 110 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.82589365 |
| 111 | Huntingtons disease_Homo sapiens_hsa05016 | 0.78345629 |
| 112 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.78266679 |
| 113 | Other glycan degradation_Homo sapiens_hsa00511 | 0.77967402 |
| 114 | Carbon metabolism_Homo sapiens_hsa01200 | 0.75686750 |
| 115 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.75457437 |
| 116 | Endocytosis_Homo sapiens_hsa04144 | 0.73013626 |
| 117 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72653449 |
| 118 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.72402501 |
| 119 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.72114130 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70820481 |
| 121 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.70132481 |
| 122 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.69413776 |
| 123 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.69143547 |
| 124 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.68202033 |
| 125 | RNA transport_Homo sapiens_hsa03013 | 0.67830552 |
| 126 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.67417754 |
| 127 | Basal transcription factors_Homo sapiens_hsa03022 | 0.66994726 |
| 128 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.65189973 |
| 129 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.64591482 |
| 130 | Alzheimers disease_Homo sapiens_hsa05010 | 0.64508592 |
| 131 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.63993417 |
| 132 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.63366740 |
| 133 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.63167685 |
| 134 | RNA degradation_Homo sapiens_hsa03018 | 0.62590375 |
| 135 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.62205180 |
| 136 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.61796793 |
| 137 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.59874591 |
| 138 | Influenza A_Homo sapiens_hsa05164 | 0.59338511 |
| 139 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58199382 |
| 140 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.58182770 |
| 141 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57833289 |
| 142 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.57537587 |
| 143 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.56777670 |
| 144 | Tuberculosis_Homo sapiens_hsa05152 | 0.56325039 |
| 145 | Prostate cancer_Homo sapiens_hsa05215 | 0.55895477 |
| 146 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.55511350 |
| 147 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.53879764 |
| 148 | Cell cycle_Homo sapiens_hsa04110 | 0.53395355 |
| 149 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53177983 |
| 150 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52554680 |
| 151 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.50918164 |
| 152 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50893187 |
| 153 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50176077 |
| 154 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49786994 |
| 155 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.48255393 |
| 156 | Colorectal cancer_Homo sapiens_hsa05210 | 0.48113752 |
| 157 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.48068409 |
| 158 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47612204 |
| 159 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46940989 |
| 160 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.45058249 |
| 161 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44288329 |
| 162 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.44154131 |
| 163 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.43927722 |
| 164 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42781057 |
| 165 | Shigellosis_Homo sapiens_hsa05131 | 0.42179782 |
| 166 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41755637 |
| 167 | Lysine degradation_Homo sapiens_hsa00310 | 0.41697780 |
| 168 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41280889 |
| 169 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.41099665 |
| 170 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40735395 |
| 171 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.39836241 |
| 172 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.39260261 |
| 173 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.38377884 |
| 174 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36282414 |
| 175 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.36058051 |
| 176 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.35723434 |
| 177 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.35033000 |
| 178 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.34851731 |
| 179 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.34768521 |

